From the category archives:

MedWatch

Ibuprofen and Oxcarbazepine Tablets by American Health Packaging: Recall – Mislabeled Packaging

July 21, 2014

Failure to receive the proper dose of oxcarbazepine could increase the chances of patients having a seizure and inadvertent consumption of ibuprofen may cause adverse reactions. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. [...]

Read More Details →

Sterile Drug Products by Downing Labs (aka NuVision Pharmacy): Drug Alert – Lack of Sterility Assurance

July 18, 2014

Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original [...]

Read More Details →

Baxter IV Sodium Chloride and Potassium Chloride Solutions: Recall – Particulate Matter

July 18, 2014

If infused, the presence of particulate foreign matter may elicit inflammatory and allergic responses, both chronic and acute, and may be life threatening. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details [...]

Read More Details →

Sterile Drug Products by Unique Pharmaceuticals Ltd.: Recall – Lack of Sterility Assurance

July 11, 2014

Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original [...]

Read More Details →

Sterile Drug Products by Unique Pharmaceuticals Ltd.: Alerting HealthCare Professionals – Lack of Sterility Assurance

July 11, 2014

Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original [...]

Read More Details →

Sterile Drug Products by Unique Pharmaceuticals Ltd.: Alerting Health Care Professionals – Lack of Sterility Assurance

July 11, 2014

Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original [...]

Read More Details →

Hospira Lactated Ringer’s And 5% Dextrose Injection, 1000 ML, Flexible Containers: Recall (One Lot) – Mold Contamination

July 11, 2014

Voluntary Nationwide Recall Of One Lot. Intravenous administration of a non-sterile product can result in infections that may be life-threatening, and may result in prolonged hospitalization or organ failure. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to [...]

Read More Details →

Weight Loss Products: Public Notification – Undeclared Drug Ingredients

July 9, 2014

May present significant risk for patients with history of CAD, CHF, arrhythmias, or stroke. May interact, in life-threatening ways, with other medications. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of [...]

Read More Details →

Langston V2 Dual Lumen Catheters (Models 5540 and 5550) by Vascular Solutions: Class I Recall – Inner Catheter May Separate During Use and Cause Injury

July 7, 2014

The use of affected product may cause serious adverse health consequences, including death. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Medtronic Duet External Drainage and Monitoring System, Medtronic Neurosurgery: Class 1 Recall – Tubing May Disconnect and Lead to Injury

July 2, 2014

Device failure may result in air within skull, infection, and over/under drainage of CSF that may contribute to serious adverse health consequences, including death. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full [...]

Read More Details →